A 4 year old boy with a rare disease, Wiskott-Aldrich Syndrome (WAS) that is characterised by eczema, low platelet count and immune deficiency has been successfully treated with an unrelated cord blood transplant and 14 months post-transplant he is now free of eczema and bleeding episodes. This case suggests that unrelated cord blood transplants may be safe for the treatment of WAS. For more information about this read here.
BSc (Hons) Microbiology
Chief Executive Officer | Biovault Family
Biovault Family CEO, Kate Sneddon, joined Biovault in July 2009 and became Chief Executive Officer in 2016. As health industry professional her experience includes working as a microbiologist and leader at GSK for over 10 years. Her expertise in cord blood banking has been recognised in her awards, features in Parliamentary Review and Parents Guide to Cord Blood, as well as contributions to research with UCL and others.